Matthew Bell

790 total citations
9 papers, 268 citations indexed

About

Matthew Bell is a scholar working on Molecular Biology, Immunology and Infectious Diseases. According to data from OpenAlex, Matthew Bell has authored 9 papers receiving a total of 268 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 5 papers in Immunology and 1 paper in Infectious Diseases. Recurrent topics in Matthew Bell's work include Immune Cell Function and Interaction (4 papers), Immunotherapy and Immune Responses (2 papers) and Histone Deacetylase Inhibitors Research (2 papers). Matthew Bell is often cited by papers focused on Immune Cell Function and Interaction (4 papers), Immunotherapy and Immune Responses (2 papers) and Histone Deacetylase Inhibitors Research (2 papers). Matthew Bell collaborates with scholars based in United Kingdom, Netherlands and Germany. Matthew Bell's co-authors include Clare M. Lloyd, Sara A. Mathie, Lisa G. Gregory, Andrew Bush, Sejal Saglani, Darrell R. Galloway, Denis Rusalov, Peter Hobart, Gary Hermanson and Thomas G. Evans and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Chemical Communications and American Journal of Respiratory Cell and Molecular Biology.

In The Last Decade

Matthew Bell

9 papers receiving 251 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Matthew Bell United Kingdom	7	128	94	66	43	43	9	268
Christine Adhiambo United States	12	117 0.9×	89 0.9×	33 0.5×	19 0.4×	34 0.8×	14	456
Prajakta Jogdand Sweden	8	89 0.7×	90 1.0×	64 1.0×	41 1.0×	15 0.3×	13	314
Hélène Léger France	9	131 1.0×	170 1.8×	24 0.4×	23 0.5×	26 0.6×	14	350
Jennifer Maki United States	12	180 1.4×	57 0.6×	18 0.3×	43 1.0×	17 0.4×	15	387
Heather R. Hill United States	13	135 1.1×	36 0.4×	123 1.9×	31 0.7×	51 1.2×	18	419
Jennifer M. Magee United States	4	128 1.0×	175 1.9×	53 0.8×	10 0.2×	52 1.2×	5	320
Nickita Mehta United States	10	116 0.9×	113 1.2×	24 0.4×	28 0.7×	98 2.3×	14	329
Sandra S. Ojeda United States	9	173 1.4×	142 1.5×	13 0.2×	19 0.4×	57 1.3×	13	322
Amanda B. Wass United States	7	132 1.0×	71 0.8×	19 0.3×	20 0.5×	41 1.0×	12	335
H. Ralph United States	7	102 0.8×	71 0.8×	35 0.5×	22 0.5×	67 1.6×	10	313

Countries citing papers authored by Matthew Bell

Since Specialization

Citations

This map shows the geographic impact of Matthew Bell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew Bell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew Bell more than expected).

Fields of papers citing papers by Matthew Bell

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew Bell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew Bell. The network helps show where Matthew Bell may publish in the future.

Co-authorship network of co-authors of Matthew Bell

This figure shows the co-authorship network connecting the top 25 collaborators of Matthew Bell. A scholar is included among the top collaborators of Matthew Bell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew Bell. Matthew Bell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Ghiboub, Mohammed, Matthew Bell, Dovilė Sinkevičiūtė, et al.. (2023). The Epigenetic Reader Protein SP140 Regulates Dendritic Cell Activation, Maturation and Tolerogenic Potential. Current Issues in Molecular Biology. 45(5). 4228–4245. 1 indexed citations

Verhoeff, Jan, Andrew Y. F. Li Yim, V Joustra, et al.. (2022). A BET Protein Inhibitor Targeting Mononuclear Myeloid Cells Affects Specific Inflammatory Mediators and Pathways in Crohn’s Disease. Cells. 11(18). 2846–2846. 4 indexed citations

Ghiboub, Mohammed, Olaf Welting, Caroline Verseijden, et al.. (2020). Tyrosine Kinase 2 Signalling Drives Pathogenic T cells in Colitis. Journal of Crohn s and Colitis. 15(4). 617–630. 13 indexed citations

Duplessis, Christopher, Michael J. Gregory, Kenneth G. Frey, et al.. (2018). Evaluating the discriminating capacity of cell death (apoptotic) biomarkers in sepsis. Journal of Intensive Care. 6(1). 72–72. 19 indexed citations

Schilderink, Ronald, Matthew Bell, Inmaculada Rioja, et al.. (2016). BET bromodomain inhibition reduces maturation and enhances tolerogenic properties of human and mouse dendritic cells. Molecular Immunology. 79. 66–76. 23 indexed citations

Saglani, Sejal, Sara A. Mathie, Lisa G. Gregory, et al.. (2009). Pathophysiological Features of Asthma Develop in Parallel in House Dust Mite–Exposed Neonatal Mice. American Journal of Respiratory Cell and Molecular Biology. 41(3). 281–289. 76 indexed citations

Bell, Matthew, Andrew J. Clark, Andrew Marsh, et al.. (2007). A photoimmobilisation strategy that maximises exploration of chemical space in small molecule affinity selection and target discovery. Chemical Communications. 2808–2808. 15 indexed citations

Rojas, José M., Stéphanie McArdle, Matthew Bell, et al.. (2004). Peptide immunisation of HLA-DR?transgenic mice permits the identification of a novel HLA-DR?1*0101? and HLA-DR?1*0401?restricted epitope from p53. Cancer Immunology Immunotherapy. 54(3). 243–253. 21 indexed citations

Hermanson, Gary, Suezanne E. Parker, Denis Rusalov, et al.. (2004). A cationic lipid-formulated plasmid DNA vaccine confers sustained antibody-mediated protection against aerosolized anthrax spores. Proceedings of the National Academy of Sciences. 101(37). 13601–13606. 96 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact